CJ Bioscience Inc.
CJ Bioscience Inc. operates in Health Care Technology.
CJ Bioscience Inc. (311690) - Net Assets
Latest net assets as of : ₩- KRW
Based on the latest financial reports, CJ Bioscience Inc. (311690) has net assets worth ₩- KRW as of .
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (₩-) and total liabilities (₩-). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | ₩- |
| % of Total Assets | 0% |
| Annual Growth Rate | N/A |
| 5-Year Change | N/A |
| 10-Year Change | N/A |
| Growth Volatility | N/A |
CJ Bioscience Inc. - Net Assets Trend (None–None)
This chart illustrates how CJ Bioscience Inc.'s net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for CJ Bioscience Inc. (None–None)
The table below shows the annual net assets of CJ Bioscience Inc. from None to None.
| Year | Net Assets | Change |
|---|---|---|
| No yearly data available. | ||
Equity Component Analysis
This analysis shows how different components contribute to CJ Bioscience Inc.'s total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- No equity composition insights available.
CJ Bioscience Inc. Competitors by Market Cap
The table below lists competitors of CJ Bioscience Inc. ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
GEPA3F
SA:GEPA3F
|
$54.56K |
|
East Delta Flour Mills
EGX:EDFM
|
$54.56K |
|
YANGTZE OPTICAL FIBRE AND
BE:1YO
|
$54.59K |
|
Mount Logan Capital Inc. Common Stock
NASDAQ:MLCI
|
$54.59K |
|
Ceylon Tobacco Company PLC
CM:CTCN0000
|
$54.47K |
|
Black Sea Property PLC Ordinary Shares
TA:BSP
|
$54.45K |
|
Polaryx Therapeutics, Inc. Common Stock
NASDAQ:PLYX
|
$54.44K |
|
UTIMES ORD A (SHH) EQSW Exp:
SHG:688638
|
$54.39K |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in CJ Bioscience Inc.'s equity between the two most recent reporting periods.
Insufficient data available to analyze equity growth attribution.
Book Value vs Market Value Analysis
This analysis compares CJ Bioscience Inc.'s book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Insufficient data available to analyze book value vs market value.
Capital Efficiency Dashboard
This dashboard shows how efficiently CJ Bioscience Inc. utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Insufficient data available to analyze capital efficiency metrics.
Industry Comparison
This section compares CJ Bioscience Inc.'s net assets metrics with peer companies in the Health Care Technology industry.
No peer company data available for comparison.